Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes

Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes

Goals

Clinical Efficacy: GLP-1 Receptor Agonists

Addressing Patient-Related Barriers to GLP-1 Agonist Use

Promoting Adherence to GLP-1 Receptor Agonist Therapy

The Importance of Patient Education

Partnering With the Patient

Currently FDA-Approved GLP-1 Receptor Agonists

Adherent Patients More Likely to Achieve Glycemic Control

ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy

Pancreatic Safety of Incretin-based Drugs

Talking to Your Patient: Pancreatitis

Optimizing GLP-1 Receptor Agonists: Addressing Injection Phobia

Fixed Ratio Combinations: Clinical Efficacy

Key Takeaways

Abbreviations

References

References (cont)

References (cont)

References (cont)